Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes.
Ramachandran G, Chandrasekaran P, Gaikwad S, Agibothu Kupparam HK, Thiruvengadam K, Gupte N, Paradkar M, Dhanasekaran K, Sivaramakrishnan GN, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V; Cohort for Tuberculosis Research by the Indo-US Partnership (CTRIUMPh) Team.
Ramachandran G, et al. Among authors: kadam d.
Clin Infect Dis. 2020 Mar 17;70(7):1463-1470. doi: 10.1093/cid/ciz380.
Clin Infect Dis. 2020.
PMID: 31075166
Free PMC article.